Study directory

Schizophrenia studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
4306studies shown
Showing 2,449-2,460 of 4,306
Behavioral study icon
CompletedNCT01029067

Metacognitive Training in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Hamburg
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaBehavioralFrom 18 Years to 65 Years
Countries
Germany
Sponsor
Universitätsklinikum Hamburg-Eppendorf
Condition
Schizophrenia
Drug study icon
TerminatedNCT01177709

Metformin for Weight Loss in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In New York
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugA study involving a medication or substance.From 18 Years to 70 Years
Countries
United States
Sponsor
Nathan Kline Institute for Psychiatric Research
Condition
Schizophrenia
Device study icon
CompletedNCT00205608

Microglia Activation in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Amsterdam
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDeviceA study involving a tool, app, wearable, test, or medical device.From 18 Years to 40 Years
Countries
Netherlands
Sponsor
Amsterdam UMC, location VUmc
Condition
Schizophrenia
Behavioral study icon
CompletedNCT01667601

Mindfulness-based Illness Management Program for Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Jilin City
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaBehavioralFrom 18 Years to 64 Years
Countries
China, Taiwan
Sponsor
The Hong Kong Polytechnic University
Condition
Schizophrenia
Drug study icon
CompletedNCT01809158

Minocycline for Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Addis Ababa
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 64 Years
Countries
Ethiopia
Sponsor
Addis Ababa University
Condition
Schizophrenia
Other study type icon
CompletedNCT01479413

Mitochondria and Schizophrenia: Effects of Antipsychotic Drugs

This summary needs review. Please check the official study record and contact the research team for details.

In Kaohsiung City
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaObservationalA study where researchers collect information without assigning a treatment.From 18 Years to 65 Years
Countries
Taiwan
Sponsor
Chang Gung Memorial Hospital
Condition
Schizophrenia
Drug study icon
CompletedNCT00506077

MK0249 for Cognitive Impairment in people with Schizophrenia (0249-016)

This summary needs review. Please check the official study record and contact the research team for details.

Location not clearly listed
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 21 Years to 55 Years
Countries
Sponsor
Merck Sharp & Dohme LLC
Condition
Schizophrenia
Drug study icon
CompletedNCT00482430

MK0557 for Cognitive Impairment in people with Schizophrenia (0557-027)

This summary needs review. Please check the official study record and contact the research team for details.

Location not clearly listed
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 21 Years to 55 Years
Countries
Sponsor
Merck Sharp & Dohme LLC
Condition
Schizophrenia
Drug study icon
CompletedNCT00711464

Modafinil Effects on Cognition in Schizophrenia Patients

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Los Angeles
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 54 Years
Countries
United States
Sponsor
University of California, Los Angeles
Condition
Schizophrenia
Other study type icon
CompletedNCT00006418

Molecular Genetics of Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Irvine
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaObservationalOver 18 Years
Countries
United States, Australia
Sponsor
Endeavor Health
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.